跳至主要内容
临床试验/NCT01926730
NCT01926730已完成不适用

Food and Crohn's Exacerbation Study (FACES)

University of Pennsylvania2 个研究点 分布在 1 个国家目标入组 216 人开始时间: 2013年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
216
试验地点
2
主要终点
Relapse of Crohn's Disease (CD)

研究概览

简要总结

The proposed study is a randomized controlled trial of a limited restriction diet compared to a regular diet among patients with Crohn's disease (CD) in remission. At baseline, patients will complete a semi-quantitative food frequency questionnaire assessing usual dietary patterns over the preceding month. Disease activity will be assessed with the abbreviated Crohn's Disease Activity Index (aCDAI)59. Self-reported disease status will be assessed during follow-up using an internet-based questionnaire. Repeat assessment of adherence to the study diets will be assessed with food frequency questionnaires (FFQs) administered after 20 weeks. Follow-up duration will be for 48 weeks. Statistical analysis will compare the time to relapse using Cox regression for patients in the two study arms. In the exploratory aim, we will compare outcomes among patients in the highest tertile for other food items and nutrients to those in the lowest tertile based on self-reported usual dietary patterns at baseline. Thus, the study population will be analyzed both as a randomized controlled trial and as a prospective cohort study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients must have an established diagnosis of CD.
  • All patients must be in clinical remission at the time of entry into the study. Remission is defined as an aCDAI of less than 150.

排除标准

  • Inflammatory bowel disease (IBD) unspecified / Indeterminate colitis
  • Total or sub-total colectomy, ileostomy, or colostomy
  • Unable to read and speak English
  • No internet access
  • Steroids other than budesonide ≤6mg/day with the prior two weeks
  • Perianal fistula or abscess with more than scant drainage
  • Age less than 18 years
  • Pregnant or breastfeeding women
  • Unwilling to follow the study diet

结局指标

主要结局

Relapse of Crohn's Disease (CD)

时间窗: Every 8 weeks during the 48 week study period

Relapse of CD is defined as an increase in the aCDAI by \>=60 points and to \>150. Additionally, undergoing CD surgery or starting any new CD medication (steroids, mesalamine, azathioprine, methotrexate, anti-Tumor Necrosis Factor α (anti-TNF), anti-α4) for the treatment of CD symptoms during the interval between two visits will be considered to have identified a clinical relapse.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验